KOrean Borderline Ovarian Tumor (KOBOT) Registry
ConditionOvarian Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorKangbuk Samsung Hospital
About this trial
The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea.
All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015
Disqualifiers
Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis
Trial population
Korean patients with borderline ovarian tumors (BOTs)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Recurrence-free survival
Time frame
up to 100 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov